Handbook of Lipoprotein TestingNader Rifai, G. Russell Warnick, Marek H. Dominiczak |
From inside the book
Results 1-5 of 82
Page v
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page xvii
... Clinical Significance of High - Density Lipoprotein Subclasses G. Russell Warnick and Marian C. Cheung 311 16 Measurement and Clinical Significance of Low - Density Lipoprotein Subclasses 329 John E. Hokanson 17 Lipoprotein ( a ) ...
... Clinical Significance of High - Density Lipoprotein Subclasses G. Russell Warnick and Marian C. Cheung 311 16 Measurement and Clinical Significance of Low - Density Lipoprotein Subclasses 329 John E. Hokanson 17 Lipoprotein ( a ) ...
Page xviii
... Clinical Significance of Lecithin : Cholesterol Acyltransferase P. Haydn Pritchard 507 Determination and Clinical Significance of Phospholipids 521 Papasani V. Subbaiah 26 Determination and Clinical Significance of Nonesterified Fatty ...
... Clinical Significance of Lecithin : Cholesterol Acyltransferase P. Haydn Pritchard 507 Determination and Clinical Significance of Phospholipids 521 Papasani V. Subbaiah 26 Determination and Clinical Significance of Nonesterified Fatty ...
Page xxi
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page xxiii
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Contents
Atherogenesis | 31 |
Genetics Markers to Predict Cardiovascular Disease | 47 |
CReactive Protein | 61 |
Overview of the Diagnosis and Treatment of Lipid | 77 |
Review of International Guidelines for the Diagnosis | 127 |
Preanalytical Variation in Lipid Lipoprotein | 161 |
a Measurement of Cholesterol Concentration | 189 |
Measurement of Triglyceride Concentration | 207 |
Determination and Clinical Significance of Lipoprotein | 479 |
Determination and Clinical Significance of Cholesteryl | 499 |
Measurement and Clinical Significance | 507 |
Determination and Clinical Significance of Phospholipids | 521 |
Determination and Clinical Significance of Nonesterified | 537 |
Measurement and Clinical Significance of Lipoprotein | 549 |
Determination and Clinical Significance | 565 |
Determination and Significance | 581 |
Measurement of HighDensityLipoprotein Cholesterol | 221 |
Measurement of LowDensity Lipoprotein Cholesterol | 245 |
Lipid and Lipoprotein Analysis with Desktop Analyzers | 265 |
Measurement and Clinical Significance | 287 |
Measurement and Clinical Significance of HighDensity | 311 |
Measurement and Clinical Significance of LowDensity | 329 |
Structure Measurement and Clinical | 345 |
Immunological Assays of Apolipoproteins AII AIV CI | 387 |
Laboratory Determinations | 403 |
Indirect Assays of Lipid Peroxidation | 441 |
Direct Measures of Lipid Peroxidation | 465 |
New Approaches to the Use of Lipoprotein | 593 |
Measurement of Lipoprotein Subclass Profiles | 609 |
The Use of Ultracentrifugation for the Separation | 625 |
Analysis of Plasma Lipoproteins by Gel Permeation | 647 |
Consideration of the Clinical Utility of Tests of Three | 671 |
Matrix Effects in the Measurement and Standardization | 695 |
Standardization of Lipid and Lipoprotein Measurements | 717 |
Providing Laboratory Support for Clinical Trials | 749 |
Regulatory Aspects of Lipid and Lipoprotein | 767 |
795 | |
Common terms and phrases
A-II activity allele analysis analytical antibodies apo A-I apo(a Arterioscler Thromb assay assessment associated atherosclerosis Biochem blood calibration cardiovascular cells CHD risk cholesteryl ester chylomicrons Clin Chem Clin Invest clinical laboratories concentrations coronary artery disease coronary heart disease decrease density diabetes diabetes mellitus diagnostic drug dyslipidemia effect electrophoresis enzyme evaluation familial hypercholesterolemia fatty acids fraction gene genetic genotype gradient guidelines HDL-C heparin high-density lipoprotein HPLC hs-CRP human hypercholesterolemia increased isoforms kg/L LCAT LDL receptor LDL-C levels lipase lipid lipid and lipoprotein Lipid Res lipo lipoprotein cholesterol lipoprotein lipase low-density lipoprotein Lp(a LpA-I matrix measurement metabolism mg/dL mmol/L mutations myocardial infarction NCEP oxidation patients phenotype phospholipids plaque plasma plasma lipoproteins polymorphism Program protein quantitation reagent reference materials reference method remnants risk factors samples serum specimens standard studies subclasses subfractions therapy tion treatment trial triglyceride tube ultracentrifugation values VLDL
References to this book
Tietz's Applied Laboratory Medicine Mitchell G. Scott,Ann M. Gronowski,Charles S. Eby No preview available - 2007 |